StockData
Calidi Biotherapeutics, Inc. logo

Calidi Biotherapeutics, Inc. (CLDI) stock

CLDINYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CLDWW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$0.53−0.03 (-5.79%)

Close on Nov 18, 2026Market cap $1.36MP/E –Yield –

Calidi Biotherapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Calidi Biotherapeutics's market cap was $1.41M on Nov 11, 2026, against $166.86M a year earlier. Over the last 5 years it ranged from $1.41M to $44.16B, with a median of $1.47B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.41M-98.9%
2025Dec 31, 2025$129.29M-93.7%
2024Dec 31, 2024$2.06B-80.0%
2023Dec 29, 2023$10.27B+27.5%
2022Dec 30, 2022$8.06B–

More Calidi Biotherapeutics figures

See a number that looks wrong?